RenovoRx RNXT
NASDAQ RNXT
$1.22 +0.04 (+3.39%)
At close: Nov 11, 2026 · 4:00 PM EST

RenovoRx (RNXT) EBITDA (2025 - 2026)

Updated

RenovoRx (RNXT) recorded EBITDA of -$3.34 million in Q2 2026, compared with -$1.68 million a year earlier.

Analysis

RenovoRx (RNXT) EBITDA (2025 - 2026) Analysis & Trends

On a TTM basis, RenovoRx's EBITDA came in at -$12.53 million as of Jun 30, 2026; for FY2025, it came in at -$10.51 million.

  • Across earlier years, EBITDA came in at -$10.97 million in FY2024.
  • Quarterly EBITDA has ranged from -$3.52 million in Q4 2025 to -$1.68 million in Q2 2025 over the past five years.
  • Per Business Quant, the preceding three quarters came in at -$3.47 million (Q1 2026), -$3.52 million (Q4 2025) and -$2.2 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA (Qtr)
1 Thermo Fisher Scientific 266.22 Bn 242.86 Bn 5.13 Bn 3.09 Bn
2 Abbott Laboratories 191.31 Bn 165.77 Bn 7.39 Bn 2.61 Bn
3 Danaher 166.16 Bn 145.82 Bn 3.84 Bn 1.97 Bn
4 Intuitive Surgical 155.98 Bn 136.40 Bn 2.08 Bn 789.70 Mn
5 Medtronic 130.05 Bn 96.18 Bn 6.34 Bn 2.49 Bn
6 Stryker 123.40 Bn 109.59 Bn 4.25 Bn -
7 Boston Scientific 64.81 Bn 60.48 Bn 3.43 Bn 1.19 Bn
8 Edwards Lifesciences 59.87 Bn 43.18 Bn 1.35 Bn 344.00 Mn
9 Medline 53.84 Bn 50.96 Bn 1.93 Bn 769.00 Mn
10 RenovoRx 56.86 Mn 17.54 Mn 878,000.00 -3.23 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -3.23 Mn
Jun 30, 2026 -3.34 Mn
Mar 31, 2026 -3.47 Mn
Dec 31, 2025 -3.52 Mn
Sep 30, 2025 -2.20 Mn
Jun 30, 2025 -1.68 Mn
Mar 31, 2025 -3.11 Mn
API Access

RenovoRx EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda&ticker=RNXT&period=max&api_key=YOUR_API_KEY